Patent ID: 11958830
Assignee: WESTLAKE PHARMACEUTICALS (HANGZHOU) CO., LTD.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 25:
26. The compound, tautomer, deuterated derivative, or pharmaceutically acceptable salt according to claim 25, wherein R2, for each occurrence, is independently selected from F, Cl, Br, cyano, C1-C2 alkyl, —C(═O)NRpRq, and —ORs; wherein:
the C1-C2 alkyl of R2 is optionally substituted is optionally substituted with 1 to 3 groups of halogen;
Rp and Rq, for each occurrence, are each independently selected from hydrogen and —CH3; and
Rs, for each occurrence, is independently selected from hydrogen and C1-C2 alkyl.